Company news

Invex Therapeutics Ltd. news in 2021

Invex Therapeutics Ltd.'s news releases, calls and decks from 2021, newest first.

View company

Appointment IIH EVOLVE Phase III Trial Steering Group Chair

December 16, 2021

Invex Therapeutics: Chairman's Address to Shareholders at AGM

November 25, 2021

Global Phase 3 Trial of Presendin to Launch in Q4 2021

November 3, 2021

Notice of Investor Call and Presentation

September 27, 2021

Exclusive Collaboration and Manufacturing Agreement

September 27, 2021

Appendix 4E and Annual Report

August 26, 2021

Invex Granted Key European Patent for Exenatide

August 16, 2021

Invex Receives Written Response from FDA on Type C Meeting

June 14, 2021

Invex Granted Type C Meeting with FDA

April 21, 2021

Appendix 4C - quarterly

April 12, 2021

Decks in 2021